e-learning
resources
ERJ
2017
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Large cell neuroendocrine carcinoma of the lung: chemotherapy regimen depends on how “large” your diagnostic criteria are
Giulio Rossi, Lucia Longo, Fausto Barbieri, Federica Bertolini, Paolo Spagnolo
Source:
Eur Respir J, 50 (4) 1701292; 10.1183/13993003.01292-2017
Journal Issue:
October
Disease area:
Thoracic oncology
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Giulio Rossi, Lucia Longo, Fausto Barbieri, Federica Bertolini, Paolo Spagnolo. Large cell neuroendocrine carcinoma of the lung: chemotherapy regimen depends on how “large” your diagnostic criteria are. Eur Respir J, 50 (4) 1701292; 10.1183/13993003.01292-2017
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Cisplatin/pemetrexed chemotherapy versus palliative care survival in malignant pleural mesothelioma
Lung function assessment in octogenarians with lung cancer diagnosis
Home-based telerehabilitation program using real-time monitoring and interactive exercise for patient with lung cancer: A feasibility study
Related content which might interest you:
Chemotherapy for pulmonary large cell neuroendocrine carcinomas: does the regimen matter?
Source: Eur Respir J, 49 (6) 1601838; 10.1183/13993003.01838-2016
Year: 2017
Treatment of extensive-stage small cell lung carcinoma: current status and future prospects
Source: Eur Respir J 2010; 35: 202-215
Year: 2010
Clinical characteristics of large cell neuroendocrine carcinoma of the lung
Source: Eur Respir J 2004; 24: Suppl. 48, 531s
Year: 2004
Small cell lung cancer: local control with an alternate chemoradiation schedule
Source: Eur Respir J 2001; 18: Suppl. 33, 395s
Year: 2001
Can IASLC/ATS/ERS subtype help predict response to chemotherapy in small biopsies of advanced lung adenocarcinoma?
Source: Eur Respir J 2014; 43: 1240-1242
Year: 2014
Long-term survival of the patients with advanced non small cell lung carcinomas after induction chemotherapy
Source: Eur Respir J 2005; 26: Suppl. 49, 78s
Year: 2005
Treatment of limited disease-small cell lung cancer
Source: Eur Respir Mon; 2009: 44: 299–309
Year: 2009
Radiotherapy in small cell lung cancer: patient options
Source: Virtual Congress 2020 – Thoracic oncology
Year: 2020
Respective indications of chemotherapy, radiotherapy and surgery in limited disease stage small cell lung carcinoma
Source: Annual Congress 2005 - Neuroendocrine tumours of the lung
Year: 2005
TTF-1 for prediction of response to chemotherapy in patients with locally advanced or metastatic small cell lung cancer (SCLC)
Source: Annual Congress 2012 - Treatment of lung cancer
Year: 2012
Should there be a specific management for large cell neuroendocrine carcinoma?
Source: Annual Congress 2005 - Neuroendocrine tumours of the lung
Year: 2005
Impact of radiotherapy on outcomes of nivolumab in advanced non-small cell lung cancer: a case controlled study
Source: International Congress 2018 – Lung cancer: personalised medicine
Year: 2018
Management of extensive disease-small cell lung cancer
Source: Eur Respir Mon; 2009: 44: 310–317
Year: 2009
Clinicopathological prognostic factors in operated for small cell lung carcinoma or large cell neuroendocrine carcinoma patients
Source: Annual Congress 2013 –Lung cancer resection and radiotherapy and thoracic oncology late breaking abstracts
Year: 2013
Radiotherapy vs. radio-chemotherapy of the inoperable non small cell lung cancer - a phase-III-study
Source: Eur Respir J 2001; 18: Suppl. 33, 318s
Year: 2001
Stage I-IIIa small cell lung cancer (SCLC): multimodal therapy including surgery
Source: Eur Respir J 2001; 18: Suppl. 33, 318s
Year: 2001
Chemotherapy for small cell lung cancer
Source: Annual Congress 2006 - PG12 - Small cell lung cancer management
Year: 2006
Large cell neuroendocrine carcinoma of the lung: Experience with 20 resected cases
Source: Eur Respir J 2003; 22: Suppl. 45, 250s
Year: 2003
Chemotherapy in advanced non small cell lung cancer
Source: Eur Respir J 2005; 26: Suppl. 49, 77s
Year: 2005
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept